pentobarbital will minimize the extent or effect of saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified.
pentobarbital will lessen the extent or effect of ixabepilone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
Notify your medical doctor of all drugs you happen to be at this time getting, who will advise you on any feasible drug interactions. In no way commence having, abruptly discontinue, or change the dosage of any medication devoid of your health practitioner’s suggestion.
pentobarbital will lessen the extent or impact of erlotinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the extent or result of doxorubicin liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will reduce the extent or impact of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will minimize the level or effect of colchicine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will minimize the extent or outcome of fentanyl intranasal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of fentanyl with CYP3A4 inducers could lead on to the decrease in fentanyl plasma concentrations, not enough efficacy or, maybe, progress of a withdrawal syndrome in the individual that has produced physical dependence to fentanyl.
pentobarbital will reduce the level or result of artemether/lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration with powerful CYP3A4 inducers can result in decreased serum concentrations and lack of antimalarial efficacy
pentobarbital will lessen the level or result of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will decrease the extent or outcome of parecoxib by influencing hepatic enzyme CYP2C9/10 metabolism. Use website Caution/Observe.
pentobarbital will reduce the extent or outcome of mifepristone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. CYP3A4 inducers have not been studied, coadministration not proposed by producer
pentobarbital will decrease the extent or effect of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Steer clear of coadministration of bedaquiline with powerful CYP3A4 inducers as a result of likely for reduced therapeutic impact
This isn't an entire listing of all side effects or adverse reactions which could happen from the use of this drug. Simply call your health care provider for health care suggestions about serious side effects or adverse reactions. You might also report side effects or health problems to your FDA at 1-800-FDA-1088.